nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—HTR2B—Raloxifene—osteoporosis	0.188	0.296	CbGbCtD
Trazodone—CYP3A7—Estradiol—osteoporosis	0.0496	0.0782	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0496	0.0782	CbGbCtD
Trazodone—ABCB1—Ethinyl Estradiol—osteoporosis	0.0376	0.0592	CbGbCtD
Trazodone—CYP3A5—Estradiol—osteoporosis	0.0372	0.0586	CbGbCtD
Trazodone—CYP3A4—Estropipate—osteoporosis	0.035	0.0551	CbGbCtD
Trazodone—CYP3A4—Calcitriol—osteoporosis	0.035	0.0551	CbGbCtD
Trazodone—CYP2D6—Cholecalciferol—osteoporosis	0.0283	0.0446	CbGbCtD
Trazodone—CYP3A4—Ergocalciferol—osteoporosis	0.028	0.044	CbGbCtD
Trazodone—ABCB1—Conjugated Estrogens—osteoporosis	0.0276	0.0435	CbGbCtD
Trazodone—ABCB1—Estradiol—osteoporosis	0.0242	0.0382	CbGbCtD
Trazodone—CYP3A4—Raloxifene—osteoporosis	0.0233	0.0367	CbGbCtD
Trazodone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0225	0.0355	CbGbCtD
Trazodone—CYP3A4—Cholecalciferol—osteoporosis	0.018	0.0284	CbGbCtD
Trazodone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0165	0.026	CbGbCtD
Trazodone—CYP3A4—Estradiol—osteoporosis	0.0145	0.0229	CbGbCtD
Trazodone—Abdominal pain—Calcitriol—osteoporosis	0.00033	0.00105	CcSEcCtD
Trazodone—Body temperature increased—Calcitriol—osteoporosis	0.00033	0.00105	CcSEcCtD
Trazodone—Hypoaesthesia—Estradiol—osteoporosis	0.000329	0.00105	CcSEcCtD
Trazodone—Shock—Pamidronate—osteoporosis	0.000328	0.00105	CcSEcCtD
Trazodone—Loss of consciousness—Zoledronate—osteoporosis	0.000328	0.00105	CcSEcCtD
Trazodone—Hypersensitivity—Estropipate—osteoporosis	0.000327	0.00104	CcSEcCtD
Trazodone—Vomiting—Etidronic acid—osteoporosis	0.000327	0.00104	CcSEcCtD
Trazodone—Tachycardia—Pamidronate—osteoporosis	0.000326	0.00104	CcSEcCtD
Trazodone—Rash—Etidronic acid—osteoporosis	0.000324	0.00103	CcSEcCtD
Trazodone—Dermatitis—Etidronic acid—osteoporosis	0.000324	0.00103	CcSEcCtD
Trazodone—Vertigo—Conjugated Estrogens—osteoporosis	0.000323	0.00103	CcSEcCtD
Trazodone—Hyperhidrosis—Pamidronate—osteoporosis	0.000323	0.00103	CcSEcCtD
Trazodone—Syncope—Conjugated Estrogens—osteoporosis	0.000323	0.00103	CcSEcCtD
Trazodone—Hypertension—Zoledronate—osteoporosis	0.000323	0.00103	CcSEcCtD
Trazodone—Hypersensitivity—Alendronate—osteoporosis	0.000323	0.00103	CcSEcCtD
Trazodone—Headache—Etidronic acid—osteoporosis	0.000322	0.00103	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00032	0.00102	CcSEcCtD
Trazodone—Asthenia—Estropipate—osteoporosis	0.000319	0.00102	CcSEcCtD
Trazodone—Visual impairment—Estradiol—osteoporosis	0.000319	0.00102	CcSEcCtD
Trazodone—Anorexia—Pamidronate—osteoporosis	0.000318	0.00102	CcSEcCtD
Trazodone—Chest pain—Zoledronate—osteoporosis	0.000318	0.00101	CcSEcCtD
Trazodone—Arthralgia—Zoledronate—osteoporosis	0.000318	0.00101	CcSEcCtD
Trazodone—Myalgia—Zoledronate—osteoporosis	0.000318	0.00101	CcSEcCtD
Trazodone—Palpitations—Conjugated Estrogens—osteoporosis	0.000318	0.00101	CcSEcCtD
Trazodone—Insomnia—Risedronate—osteoporosis	0.000318	0.00101	CcSEcCtD
Trazodone—Anxiety—Zoledronate—osteoporosis	0.000317	0.00101	CcSEcCtD
Trazodone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000316	0.00101	CcSEcCtD
Trazodone—Paraesthesia—Risedronate—osteoporosis	0.000315	0.00101	CcSEcCtD
Trazodone—Pruritus—Estropipate—osteoporosis	0.000314	0.001	CcSEcCtD
Trazodone—Discomfort—Zoledronate—osteoporosis	0.000314	0.001	CcSEcCtD
Trazodone—Asthenia—Alendronate—osteoporosis	0.000314	0.001	CcSEcCtD
Trazodone—Hypersensitivity—Ibandronate—osteoporosis	0.000314	0.001	CcSEcCtD
Trazodone—Dyspnoea—Risedronate—osteoporosis	0.000313	0.000999	CcSEcCtD
Trazodone—Hypotension—Pamidronate—osteoporosis	0.000312	0.000995	CcSEcCtD
Trazodone—Dry mouth—Zoledronate—osteoporosis	0.000311	0.000993	CcSEcCtD
Trazodone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000311	0.000991	CcSEcCtD
Trazodone—Pruritus—Alendronate—osteoporosis	0.00031	0.000988	CcSEcCtD
Trazodone—Tinnitus—Estradiol—osteoporosis	0.000308	0.000984	CcSEcCtD
Trazodone—Constipation—Ethinyl Estradiol—osteoporosis	0.000308	0.000983	CcSEcCtD
Trazodone—Confusional state—Zoledronate—osteoporosis	0.000308	0.000981	CcSEcCtD
Trazodone—Hypersensitivity—Calcitriol—osteoporosis	0.000307	0.000981	CcSEcCtD
Trazodone—Flushing—Estradiol—osteoporosis	0.000307	0.000979	CcSEcCtD
Trazodone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000306	0.000977	CcSEcCtD
Trazodone—Myalgia—Conjugated Estrogens—osteoporosis	0.000306	0.000977	CcSEcCtD
Trazodone—Chest pain—Conjugated Estrogens—osteoporosis	0.000306	0.000977	CcSEcCtD
Trazodone—Asthenia—Ibandronate—osteoporosis	0.000306	0.000975	CcSEcCtD
Trazodone—Anxiety—Conjugated Estrogens—osteoporosis	0.000305	0.000974	CcSEcCtD
Trazodone—Nausea—Etidronic acid—osteoporosis	0.000305	0.000973	CcSEcCtD
Trazodone—Oedema—Zoledronate—osteoporosis	0.000305	0.000973	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000304	0.00097	CcSEcCtD
Trazodone—Diarrhoea—Estropipate—osteoporosis	0.000304	0.00097	CcSEcCtD
Trazodone—Fatigue—Risedronate—osteoporosis	0.000303	0.000966	CcSEcCtD
Trazodone—Insomnia—Pamidronate—osteoporosis	0.000302	0.000963	CcSEcCtD
Trazodone—Pruritus—Ibandronate—osteoporosis	0.000302	0.000962	CcSEcCtD
Trazodone—Constipation—Risedronate—osteoporosis	0.0003	0.000958	CcSEcCtD
Trazodone—Pain—Risedronate—osteoporosis	0.0003	0.000958	CcSEcCtD
Trazodone—Shock—Zoledronate—osteoporosis	0.0003	0.000957	CcSEcCtD
Trazodone—Paraesthesia—Pamidronate—osteoporosis	0.0003	0.000956	CcSEcCtD
Trazodone—Diarrhoea—Alendronate—osteoporosis	0.0003	0.000955	CcSEcCtD
Trazodone—Asthenia—Calcitriol—osteoporosis	0.000299	0.000955	CcSEcCtD
Trazodone—Dyspnoea—Pamidronate—osteoporosis	0.000298	0.00095	CcSEcCtD
Trazodone—Tachycardia—Zoledronate—osteoporosis	0.000298	0.00095	CcSEcCtD
Trazodone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000297	0.000947	CcSEcCtD
Trazodone—Chills—Estradiol—osteoporosis	0.000297	0.000947	CcSEcCtD
Trazodone—Somnolence—Pamidronate—osteoporosis	0.000297	0.000947	CcSEcCtD
Trazodone—Pruritus—Calcitriol—osteoporosis	0.000295	0.000942	CcSEcCtD
Trazodone—Hyperhidrosis—Zoledronate—osteoporosis	0.000295	0.000941	CcSEcCtD
Trazodone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000295	0.00094	CcSEcCtD
Trazodone—Diarrhoea—Raloxifene—osteoporosis	0.000295	0.00094	CcSEcCtD
Trazodone—Dizziness—Estropipate—osteoporosis	0.000294	0.000938	CcSEcCtD
Trazodone—Oedema—Conjugated Estrogens—osteoporosis	0.000294	0.000937	CcSEcCtD
Trazodone—Alopecia—Estradiol—osteoporosis	0.000292	0.000933	CcSEcCtD
Trazodone—Diarrhoea—Ibandronate—osteoporosis	0.000292	0.00093	CcSEcCtD
Trazodone—Anorexia—Zoledronate—osteoporosis	0.000291	0.000927	CcSEcCtD
Trazodone—Decreased appetite—Pamidronate—osteoporosis	0.00029	0.000926	CcSEcCtD
Trazodone—Dizziness—Alendronate—osteoporosis	0.000289	0.000923	CcSEcCtD
Trazodone—Shock—Conjugated Estrogens—osteoporosis	0.000289	0.000922	CcSEcCtD
Trazodone—Fatigue—Pamidronate—osteoporosis	0.000288	0.000918	CcSEcCtD
Trazodone—Gastrointestinal pain—Risedronate—osteoporosis	0.000287	0.000916	CcSEcCtD
Trazodone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000287	0.000914	CcSEcCtD
Trazodone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000286	0.000913	CcSEcCtD
Trazodone—Pain—Pamidronate—osteoporosis	0.000286	0.000911	CcSEcCtD
Trazodone—Constipation—Pamidronate—osteoporosis	0.000286	0.000911	CcSEcCtD
Trazodone—Diarrhoea—Calcitriol—osteoporosis	0.000285	0.000911	CcSEcCtD
Trazodone—Hypotension—Zoledronate—osteoporosis	0.000285	0.000909	CcSEcCtD
Trazodone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000285	0.000908	CcSEcCtD
Trazodone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000285	0.000908	CcSEcCtD
Trazodone—Dizziness—Raloxifene—osteoporosis	0.000285	0.000908	CcSEcCtD
Trazodone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000284	0.000906	CcSEcCtD
Trazodone—Flatulence—Estradiol—osteoporosis	0.000284	0.000905	CcSEcCtD
Trazodone—Tension—Estradiol—osteoporosis	0.000283	0.000902	CcSEcCtD
Trazodone—Vomiting—Estropipate—osteoporosis	0.000283	0.000901	CcSEcCtD
Trazodone—Dysgeusia—Estradiol—osteoporosis	0.000282	0.0009	CcSEcCtD
Trazodone—Dizziness—Ibandronate—osteoporosis	0.000282	0.000899	CcSEcCtD
Trazodone—Rash—Estropipate—osteoporosis	0.00028	0.000894	CcSEcCtD
Trazodone—Dermatitis—Estropipate—osteoporosis	0.00028	0.000893	CcSEcCtD
Trazodone—Anorexia—Conjugated Estrogens—osteoporosis	0.00028	0.000893	CcSEcCtD
Trazodone—Nervousness—Estradiol—osteoporosis	0.00028	0.000892	CcSEcCtD
Trazodone—Urticaria—Risedronate—osteoporosis	0.000279	0.00089	CcSEcCtD
Trazodone—Back pain—Estradiol—osteoporosis	0.000279	0.000889	CcSEcCtD
Trazodone—Headache—Estropipate—osteoporosis	0.000278	0.000888	CcSEcCtD
Trazodone—Vomiting—Alendronate—osteoporosis	0.000278	0.000888	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000278	0.000886	CcSEcCtD
Trazodone—Abdominal pain—Risedronate—osteoporosis	0.000278	0.000886	CcSEcCtD
Trazodone—Body temperature increased—Risedronate—osteoporosis	0.000278	0.000886	CcSEcCtD
Trazodone—Rash—Alendronate—osteoporosis	0.000276	0.00088	CcSEcCtD
Trazodone—Insomnia—Zoledronate—osteoporosis	0.000276	0.00088	CcSEcCtD
Trazodone—Dermatitis—Alendronate—osteoporosis	0.000276	0.00088	CcSEcCtD
Trazodone—Feeling abnormal—Pamidronate—osteoporosis	0.000275	0.000878	CcSEcCtD
Trazodone—Hypotension—Conjugated Estrogens—osteoporosis	0.000274	0.000875	CcSEcCtD
Trazodone—Headache—Alendronate—osteoporosis	0.000274	0.000875	CcSEcCtD
Trazodone—Paraesthesia—Zoledronate—osteoporosis	0.000274	0.000874	CcSEcCtD
Trazodone—Vomiting—Raloxifene—osteoporosis	0.000274	0.000873	CcSEcCtD
Trazodone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000273	0.000871	CcSEcCtD
Trazodone—Dyspnoea—Zoledronate—osteoporosis	0.000272	0.000867	CcSEcCtD
Trazodone—Rash—Raloxifene—osteoporosis	0.000271	0.000866	CcSEcCtD
Trazodone—Dermatitis—Raloxifene—osteoporosis	0.000271	0.000865	CcSEcCtD
Trazodone—Somnolence—Zoledronate—osteoporosis	0.000271	0.000865	CcSEcCtD
Trazodone—Vomiting—Ibandronate—osteoporosis	0.000271	0.000864	CcSEcCtD
Trazodone—Tremor—Estradiol—osteoporosis	0.00027	0.000861	CcSEcCtD
Trazodone—Headache—Raloxifene—osteoporosis	0.00027	0.00086	CcSEcCtD
Trazodone—Rash—Ibandronate—osteoporosis	0.000269	0.000857	CcSEcCtD
Trazodone—Dermatitis—Ibandronate—osteoporosis	0.000268	0.000856	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000268	0.000854	CcSEcCtD
Trazodone—Ill-defined disorder—Estradiol—osteoporosis	0.000267	0.000852	CcSEcCtD
Trazodone—Headache—Ibandronate—osteoporosis	0.000267	0.000852	CcSEcCtD
Trazodone—Insomnia—Conjugated Estrogens—osteoporosis	0.000266	0.000847	CcSEcCtD
Trazodone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000265	0.000847	CcSEcCtD
Trazodone—Vomiting—Calcitriol—osteoporosis	0.000265	0.000846	CcSEcCtD
Trazodone—Decreased appetite—Zoledronate—osteoporosis	0.000265	0.000846	CcSEcCtD
Trazodone—Agitation—Estradiol—osteoporosis	0.000265	0.000844	CcSEcCtD
Trazodone—Nausea—Estropipate—osteoporosis	0.000264	0.000842	CcSEcCtD
Trazodone—Abdominal pain—Pamidronate—osteoporosis	0.000264	0.000842	CcSEcCtD
Trazodone—Body temperature increased—Pamidronate—osteoporosis	0.000264	0.000842	CcSEcCtD
Trazodone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000264	0.000841	CcSEcCtD
Trazodone—Rash—Calcitriol—osteoporosis	0.000263	0.000839	CcSEcCtD
Trazodone—Fatigue—Zoledronate—osteoporosis	0.000263	0.000839	CcSEcCtD
Trazodone—Dermatitis—Calcitriol—osteoporosis	0.000263	0.000838	CcSEcCtD
Trazodone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000262	0.000835	CcSEcCtD
Trazodone—Headache—Calcitriol—osteoporosis	0.000261	0.000834	CcSEcCtD
Trazodone—Somnolence—Conjugated Estrogens—osteoporosis	0.000261	0.000833	CcSEcCtD
Trazodone—Constipation—Zoledronate—osteoporosis	0.000261	0.000832	CcSEcCtD
Trazodone—Pain—Zoledronate—osteoporosis	0.000261	0.000832	CcSEcCtD
Trazodone—Nausea—Alendronate—osteoporosis	0.00026	0.000829	CcSEcCtD
Trazodone—Malaise—Estradiol—osteoporosis	0.00026	0.000828	CcSEcCtD
Trazodone—Hypersensitivity—Risedronate—osteoporosis	0.000259	0.000826	CcSEcCtD
Trazodone—Vertigo—Estradiol—osteoporosis	0.000259	0.000825	CcSEcCtD
Trazodone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000258	0.000825	CcSEcCtD
Trazodone—Syncope—Estradiol—osteoporosis	0.000258	0.000824	CcSEcCtD
Trazodone—Nausea—Raloxifene—osteoporosis	0.000256	0.000816	CcSEcCtD
Trazodone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000255	0.000814	CcSEcCtD
Trazodone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000255	0.000813	CcSEcCtD
Trazodone—Palpitations—Estradiol—osteoporosis	0.000254	0.000812	CcSEcCtD
Trazodone—Fatigue—Conjugated Estrogens—osteoporosis	0.000253	0.000808	CcSEcCtD
Trazodone—Nausea—Ibandronate—osteoporosis	0.000253	0.000808	CcSEcCtD
Trazodone—Loss of consciousness—Estradiol—osteoporosis	0.000253	0.000807	CcSEcCtD
Trazodone—Asthenia—Risedronate—osteoporosis	0.000252	0.000804	CcSEcCtD
Trazodone—Feeling abnormal—Zoledronate—osteoporosis	0.000251	0.000802	CcSEcCtD
Trazodone—Pain—Conjugated Estrogens—osteoporosis	0.000251	0.000801	CcSEcCtD
Trazodone—Constipation—Conjugated Estrogens—osteoporosis	0.000251	0.000801	CcSEcCtD
Trazodone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000249	0.000796	CcSEcCtD
Trazodone—Hypertension—Estradiol—osteoporosis	0.000249	0.000793	CcSEcCtD
Trazodone—Pruritus—Risedronate—osteoporosis	0.000248	0.000793	CcSEcCtD
Trazodone—Nausea—Calcitriol—osteoporosis	0.000248	0.000791	CcSEcCtD
Trazodone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000246	0.000786	CcSEcCtD
Trazodone—Hypersensitivity—Pamidronate—osteoporosis	0.000246	0.000785	CcSEcCtD
Trazodone—Arthralgia—Estradiol—osteoporosis	0.000245	0.000782	CcSEcCtD
Trazodone—Chest pain—Estradiol—osteoporosis	0.000245	0.000782	CcSEcCtD
Trazodone—Myalgia—Estradiol—osteoporosis	0.000245	0.000782	CcSEcCtD
Trazodone—Anxiety—Estradiol—osteoporosis	0.000244	0.000779	CcSEcCtD
Trazodone—Urticaria—Zoledronate—osteoporosis	0.000242	0.000773	CcSEcCtD
Trazodone—Discomfort—Estradiol—osteoporosis	0.000242	0.000773	CcSEcCtD
Trazodone—Body temperature increased—Zoledronate—osteoporosis	0.000241	0.000769	CcSEcCtD
Trazodone—Abdominal pain—Zoledronate—osteoporosis	0.000241	0.000769	CcSEcCtD
Trazodone—Diarrhoea—Risedronate—osteoporosis	0.00024	0.000767	CcSEcCtD
Trazodone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00024	0.000766	CcSEcCtD
Trazodone—Dry mouth—Estradiol—osteoporosis	0.00024	0.000765	CcSEcCtD
Trazodone—Asthenia—Pamidronate—osteoporosis	0.00024	0.000764	CcSEcCtD
Trazodone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000238	0.00076	CcSEcCtD
Trazodone—Confusional state—Estradiol—osteoporosis	0.000237	0.000756	CcSEcCtD
Trazodone—Pruritus—Pamidronate—osteoporosis	0.000236	0.000754	CcSEcCtD
Trazodone—Oedema—Estradiol—osteoporosis	0.000235	0.00075	CcSEcCtD
Trazodone—Urticaria—Conjugated Estrogens—osteoporosis	0.000233	0.000744	CcSEcCtD
Trazodone—Dizziness—Risedronate—osteoporosis	0.000232	0.000741	CcSEcCtD
Trazodone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000232	0.000741	CcSEcCtD
Trazodone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000232	0.000741	CcSEcCtD
Trazodone—Shock—Estradiol—osteoporosis	0.000231	0.000738	CcSEcCtD
Trazodone—Tachycardia—Estradiol—osteoporosis	0.000229	0.000732	CcSEcCtD
Trazodone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000229	0.000731	CcSEcCtD
Trazodone—Diarrhoea—Pamidronate—osteoporosis	0.000228	0.000729	CcSEcCtD
Trazodone—Hyperhidrosis—Estradiol—osteoporosis	0.000227	0.000725	CcSEcCtD
Trazodone—Rash—Ethinyl Estradiol—osteoporosis	0.000227	0.000725	CcSEcCtD
Trazodone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000227	0.000724	CcSEcCtD
Trazodone—Headache—Ethinyl Estradiol—osteoporosis	0.000226	0.00072	CcSEcCtD
Trazodone—Hypersensitivity—Zoledronate—osteoporosis	0.000225	0.000717	CcSEcCtD
Trazodone—Vomiting—Risedronate—osteoporosis	0.000223	0.000712	CcSEcCtD
Trazodone—Rash—Risedronate—osteoporosis	0.000221	0.000706	CcSEcCtD
Trazodone—Dermatitis—Risedronate—osteoporosis	0.000221	0.000706	CcSEcCtD
Trazodone—Dizziness—Pamidronate—osteoporosis	0.000221	0.000704	CcSEcCtD
Trazodone—Headache—Risedronate—osteoporosis	0.00022	0.000702	CcSEcCtD
Trazodone—Asthenia—Zoledronate—osteoporosis	0.000219	0.000698	CcSEcCtD
Trazodone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000216	0.00069	CcSEcCtD
Trazodone—Pruritus—Zoledronate—osteoporosis	0.000216	0.000688	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000214	0.000683	CcSEcCtD
Trazodone—Nausea—Ethinyl Estradiol—osteoporosis	0.000214	0.000683	CcSEcCtD
Trazodone—Insomnia—Estradiol—osteoporosis	0.000213	0.000678	CcSEcCtD
Trazodone—Vomiting—Pamidronate—osteoporosis	0.000212	0.000677	CcSEcCtD
Trazodone—Paraesthesia—Estradiol—osteoporosis	0.000211	0.000673	CcSEcCtD
Trazodone—Asthenia—Conjugated Estrogens—osteoporosis	0.000211	0.000672	CcSEcCtD
Trazodone—Rash—Pamidronate—osteoporosis	0.000211	0.000672	CcSEcCtD
Trazodone—Dermatitis—Pamidronate—osteoporosis	0.00021	0.000671	CcSEcCtD
Trazodone—Dyspnoea—Estradiol—osteoporosis	0.00021	0.000668	CcSEcCtD
Trazodone—Headache—Pamidronate—osteoporosis	0.000209	0.000667	CcSEcCtD
Trazodone—Somnolence—Estradiol—osteoporosis	0.000209	0.000667	CcSEcCtD
Trazodone—Diarrhoea—Zoledronate—osteoporosis	0.000209	0.000666	CcSEcCtD
Trazodone—Nausea—Risedronate—osteoporosis	0.000209	0.000666	CcSEcCtD
Trazodone—Pruritus—Conjugated Estrogens—osteoporosis	0.000208	0.000663	CcSEcCtD
Trazodone—Decreased appetite—Estradiol—osteoporosis	0.000204	0.000652	CcSEcCtD
Trazodone—Fatigue—Estradiol—osteoporosis	0.000203	0.000646	CcSEcCtD
Trazodone—Dizziness—Zoledronate—osteoporosis	0.000202	0.000643	CcSEcCtD
Trazodone—Constipation—Estradiol—osteoporosis	0.000201	0.000641	CcSEcCtD
Trazodone—Pain—Estradiol—osteoporosis	0.000201	0.000641	CcSEcCtD
Trazodone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000201	0.000641	CcSEcCtD
Trazodone—Nausea—Pamidronate—osteoporosis	0.000198	0.000633	CcSEcCtD
Trazodone—Dizziness—Conjugated Estrogens—osteoporosis	0.000194	0.00062	CcSEcCtD
Trazodone—Vomiting—Zoledronate—osteoporosis	0.000194	0.000619	CcSEcCtD
Trazodone—Feeling abnormal—Estradiol—osteoporosis	0.000194	0.000618	CcSEcCtD
Trazodone—Rash—Zoledronate—osteoporosis	0.000192	0.000613	CcSEcCtD
Trazodone—Gastrointestinal pain—Estradiol—osteoporosis	0.000192	0.000613	CcSEcCtD
Trazodone—Dermatitis—Zoledronate—osteoporosis	0.000192	0.000613	CcSEcCtD
Trazodone—Headache—Zoledronate—osteoporosis	0.000191	0.00061	CcSEcCtD
Trazodone—Vomiting—Conjugated Estrogens—osteoporosis	0.000187	0.000596	CcSEcCtD
Trazodone—Urticaria—Estradiol—osteoporosis	0.000187	0.000596	CcSEcCtD
Trazodone—Body temperature increased—Estradiol—osteoporosis	0.000186	0.000593	CcSEcCtD
Trazodone—Abdominal pain—Estradiol—osteoporosis	0.000186	0.000593	CcSEcCtD
Trazodone—Rash—Conjugated Estrogens—osteoporosis	0.000185	0.000591	CcSEcCtD
Trazodone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000185	0.00059	CcSEcCtD
Trazodone—Headache—Conjugated Estrogens—osteoporosis	0.000184	0.000587	CcSEcCtD
Trazodone—Nausea—Zoledronate—osteoporosis	0.000181	0.000578	CcSEcCtD
Trazodone—Nausea—Conjugated Estrogens—osteoporosis	0.000174	0.000556	CcSEcCtD
Trazodone—Hypersensitivity—Estradiol—osteoporosis	0.000173	0.000552	CcSEcCtD
Trazodone—Asthenia—Estradiol—osteoporosis	0.000169	0.000538	CcSEcCtD
Trazodone—Pruritus—Estradiol—osteoporosis	0.000166	0.00053	CcSEcCtD
Trazodone—Diarrhoea—Estradiol—osteoporosis	0.000161	0.000513	CcSEcCtD
Trazodone—Dizziness—Estradiol—osteoporosis	0.000155	0.000496	CcSEcCtD
Trazodone—Vomiting—Estradiol—osteoporosis	0.000149	0.000477	CcSEcCtD
Trazodone—Rash—Estradiol—osteoporosis	0.000148	0.000473	CcSEcCtD
Trazodone—Dermatitis—Estradiol—osteoporosis	0.000148	0.000472	CcSEcCtD
Trazodone—Headache—Estradiol—osteoporosis	0.000147	0.00047	CcSEcCtD
Trazodone—Nausea—Estradiol—osteoporosis	0.00014	0.000445	CcSEcCtD
Trazodone—HRH1—Signaling Pathways—DKK1—osteoporosis	2.1e-05	0.00041	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	2.1e-05	0.000409	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KL—osteoporosis	2.1e-05	0.000408	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	2.08e-05	0.000405	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—FGB—osteoporosis	2.08e-05	0.000405	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—P4HB—osteoporosis	2.07e-05	0.000404	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—FGB—osteoporosis	2.07e-05	0.000403	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DKK1—osteoporosis	2.07e-05	0.000402	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPD2—osteoporosis	2.05e-05	0.000399	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PGLS—osteoporosis	2.05e-05	0.000399	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—POMC—osteoporosis	2.04e-05	0.000398	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—WNT1—osteoporosis	2.03e-05	0.000396	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—WNT1—osteoporosis	2.03e-05	0.000395	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—IDH2—osteoporosis	2.02e-05	0.000394	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTH—osteoporosis	2.02e-05	0.000393	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP27A1—osteoporosis	2.02e-05	0.000393	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.01e-05	0.000391	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.01e-05	0.000391	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PSMA5—osteoporosis	2e-05	0.000389	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PSMA2—osteoporosis	2e-05	0.000389	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6R—osteoporosis	1.99e-05	0.000388	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—WNT1—osteoporosis	1.99e-05	0.000387	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	1.98e-05	0.000386	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.98e-05	0.000385	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FGA—osteoporosis	1.98e-05	0.000385	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.97e-05	0.000384	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FGA—osteoporosis	1.97e-05	0.000384	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CNR2—osteoporosis	1.97e-05	0.000383	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ACP5—osteoporosis	1.96e-05	0.000382	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	1.95e-05	0.00038	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	1.95e-05	0.000379	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.94e-05	0.000378	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.94e-05	0.000378	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FGA—osteoporosis	1.94e-05	0.000377	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	1.93e-05	0.000377	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DKK1—osteoporosis	1.92e-05	0.000374	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ENO1—osteoporosis	1.92e-05	0.000373	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	1.91e-05	0.000371	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.9e-05	0.00037	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PSMA2—osteoporosis	1.89e-05	0.000368	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PSMA5—osteoporosis	1.89e-05	0.000368	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ATIC—osteoporosis	1.88e-05	0.000365	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PNP—osteoporosis	1.88e-05	0.000365	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CALCA—osteoporosis	1.87e-05	0.000365	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CALCA—osteoporosis	1.86e-05	0.000363	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ACP5—osteoporosis	1.85e-05	0.00036	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—WNT1—osteoporosis	1.85e-05	0.00036	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.85e-05	0.00036	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.84e-05	0.000359	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BMP2—osteoporosis	1.84e-05	0.000358	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTHLH—osteoporosis	1.84e-05	0.000358	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.83e-05	0.000357	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BMP2—osteoporosis	1.83e-05	0.000357	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—POMC—osteoporosis	1.83e-05	0.000356	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TPI1—osteoporosis	1.82e-05	0.000355	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—POMC—osteoporosis	1.82e-05	0.000354	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	1.8e-05	0.00035	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BMP2—osteoporosis	1.8e-05	0.00035	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FGB—osteoporosis	1.8e-05	0.00035	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FGA—osteoporosis	1.8e-05	0.00035	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FGB—osteoporosis	1.79e-05	0.000349	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	1.77e-05	0.000345	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FGB—osteoporosis	1.76e-05	0.000343	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ENO1—osteoporosis	1.76e-05	0.000342	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PSMA2—osteoporosis	1.74e-05	0.000338	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PSMA5—osteoporosis	1.74e-05	0.000338	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PSMA2—osteoporosis	1.73e-05	0.000337	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PSMA5—osteoporosis	1.73e-05	0.000337	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PSMA5—osteoporosis	1.73e-05	0.000337	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PSMA2—osteoporosis	1.73e-05	0.000337	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TPI1—osteoporosis	1.72e-05	0.000335	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—P4HB—osteoporosis	1.71e-05	0.000334	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KL—osteoporosis	1.7e-05	0.000331	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	1.7e-05	0.000331	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	1.7e-05	0.000331	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KL—osteoporosis	1.69e-05	0.000329	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GAPDH—osteoporosis	1.68e-05	0.000328	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	1.67e-05	0.000325	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BMP2—osteoporosis	1.67e-05	0.000325	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.66e-05	0.000323	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—POMC—osteoporosis	1.65e-05	0.000321	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ADCY5—osteoporosis	1.64e-05	0.00032	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—RAP1A—osteoporosis	1.64e-05	0.000319	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FGB—osteoporosis	1.64e-05	0.000319	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.62e-05	0.000315	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CALCA—osteoporosis	1.62e-05	0.000315	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—P4HB—osteoporosis	1.62e-05	0.000315	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CALCA—osteoporosis	1.61e-05	0.000314	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6R—osteoporosis	1.61e-05	0.000313	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.6e-05	0.000311	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CA2—osteoporosis	1.6e-05	0.000311	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SPP1—osteoporosis	1.59e-05	0.000309	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ADCY5—osteoporosis	1.59e-05	0.000309	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GAPDH—osteoporosis	1.59e-05	0.000309	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CALCA—osteoporosis	1.58e-05	0.000308	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GPX1—osteoporosis	1.58e-05	0.000308	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.58e-05	0.000307	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.58e-05	0.000307	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—POMC—osteoporosis	1.58e-05	0.000307	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.57e-05	0.000307	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MGLL—osteoporosis	1.55e-05	0.000303	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.54e-05	0.000301	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.54e-05	0.000301	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.53e-05	0.000298	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.47e-05	0.000287	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KL—osteoporosis	1.47e-05	0.000286	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KL—osteoporosis	1.47e-05	0.000285	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—MTHFR—osteoporosis	1.46e-05	0.000284	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KL—osteoporosis	1.44e-05	0.00028	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.44e-05	0.00028	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.44e-05	0.000279	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.43e-05	0.000279	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—POMC—osteoporosis	1.43e-05	0.000278	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—LEP—osteoporosis	1.41e-05	0.000274	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.4e-05	0.000273	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.4e-05	0.000273	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.4e-05	0.000272	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.39e-05	0.000272	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.37e-05	0.000266	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.34e-05	0.000261	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KL—osteoporosis	1.34e-05	0.00026	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.33e-05	0.000259	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ENO1—osteoporosis	1.33e-05	0.000258	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.33e-05	0.000258	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—IDH2—osteoporosis	1.32e-05	0.000257	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.31e-05	0.000255	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PSMA2—osteoporosis	1.31e-05	0.000254	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PSMA5—osteoporosis	1.31e-05	0.000254	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.3e-05	0.000254	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.29e-05	0.000251	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.28e-05	0.00025	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.27e-05	0.000248	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.25e-05	0.000244	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ADCY5—osteoporosis	1.25e-05	0.000244	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ENO1—osteoporosis	1.25e-05	0.000243	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GPX1—osteoporosis	1.25e-05	0.000243	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.24e-05	0.000242	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.23e-05	0.00024	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.23e-05	0.00024	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ACP5—osteoporosis	1.21e-05	0.000235	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—POMC—osteoporosis	1.21e-05	0.000235	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.18e-05	0.000229	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—POMC—osteoporosis	1.17e-05	0.000227	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.17e-05	0.000227	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.16e-05	0.000226	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.16e-05	0.000226	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—MTHFR—osteoporosis	1.15e-05	0.000224	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.15e-05	0.000224	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.15e-05	0.000224	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.15e-05	0.000223	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GPX1—osteoporosis	1.14e-05	0.000223	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—LEP—osteoporosis	1.14e-05	0.000222	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—LEP—osteoporosis	1.13e-05	0.000221	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.13e-05	0.000219	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TPI1—osteoporosis	1.12e-05	0.000219	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.11e-05	0.000217	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SPP1—osteoporosis	1.11e-05	0.000216	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.09e-05	0.000212	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.09e-05	0.000212	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.08e-05	0.000211	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP19A1—osteoporosis	1.06e-05	0.000206	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—P4HB—osteoporosis	1.06e-05	0.000206	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—MTHFR—osteoporosis	1.06e-05	0.000205	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.05e-05	0.000204	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.04e-05	0.000202	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.02e-05	0.000198	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.01e-05	0.000197	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.01e-05	0.000197	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.01e-05	0.000197	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.01e-05	0.000196	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IRS2—osteoporosis	1e-05	0.000196	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.98e-06	0.000194	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IRS2—osteoporosis	9.86e-06	0.000192	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—LEP—osteoporosis	9.85e-06	0.000192	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—LEP—osteoporosis	9.83e-06	0.000191	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—POMC—osteoporosis	9.8e-06	0.000191	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—POMC—osteoporosis	9.75e-06	0.00019	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.65e-06	0.000188	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.56e-06	0.000186	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6R—osteoporosis	9.51e-06	0.000185	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.42e-06	0.000183	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.41e-06	0.000183	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ESR1—osteoporosis	9.39e-06	0.000183	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IGF1—osteoporosis	9.37e-06	0.000183	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ESR1—osteoporosis	9.21e-06	0.000179	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—POMC—osteoporosis	9.21e-06	0.000179	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS2—osteoporosis	9.16e-06	0.000178	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LEP—osteoporosis	8.96e-06	0.000175	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—osteoporosis	8.89e-06	0.000173	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.79e-06	0.000171	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IRS1—osteoporosis	8.77e-06	0.000171	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ADCY5—osteoporosis	8.66e-06	0.000169	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GPX1—osteoporosis	8.63e-06	0.000168	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.61e-06	0.000168	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.56e-06	0.000167	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—POMC—osteoporosis	8.46e-06	0.000165	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—POMC—osteoporosis	8.45e-06	0.000164	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—POMC—osteoporosis	8.44e-06	0.000164	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—POMC—osteoporosis	8.29e-06	0.000161	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6R—osteoporosis	8.26e-06	0.000161	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6R—osteoporosis	8.24e-06	0.00016	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ENO1—osteoporosis	8.17e-06	0.000159	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ADCY5—osteoporosis	8.16e-06	0.000159	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF1—osteoporosis	8.14e-06	0.000159	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GPX1—osteoporosis	8.13e-06	0.000158	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF1—osteoporosis	8.12e-06	0.000158	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6R—osteoporosis	8.08e-06	0.000157	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PSMA2—osteoporosis	8.05e-06	0.000157	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PSMA5—osteoporosis	8.05e-06	0.000157	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS1—osteoporosis	8e-06	0.000156	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF1—osteoporosis	7.97e-06	0.000155	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MTHFR—osteoporosis	7.96e-06	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.7e-06	0.00015	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.51e-06	0.000146	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MTHFR—osteoporosis	7.5e-06	0.000146	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1—osteoporosis	7.41e-06	0.000144	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.21e-06	0.00014	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—osteoporosis	7.17e-06	0.00014	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—osteoporosis	6.98e-06	0.000136	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—osteoporosis	6.97e-06	0.000136	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.53e-06	0.000127	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—osteoporosis	6.37e-06	0.000124	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.23e-06	0.000121	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—osteoporosis	6.21e-06	0.000121	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—osteoporosis	6.1e-06	0.000119	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—osteoporosis	6e-06	0.000117	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.66e-06	0.00011	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—osteoporosis	5.66e-06	0.00011	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.65e-06	0.00011	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—osteoporosis	5.63e-06	0.00011	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.62e-06	0.000109	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ADCY5—osteoporosis	5.33e-06	0.000104	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPX1—osteoporosis	5.32e-06	0.000103	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—osteoporosis	5.25e-06	0.000102	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MTHFR—osteoporosis	4.91e-06	9.55e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—osteoporosis	4.89e-06	9.53e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—osteoporosis	4.88e-06	9.51e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.88e-06	9.5e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.87e-06	9.48e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.79e-06	9.33e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.78e-06	9.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.45e-06	8.67e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.44e-06	8.65e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—osteoporosis	4.26e-06	8.29e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—osteoporosis	4.24e-06	8.25e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—osteoporosis	3.92e-06	7.64e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—osteoporosis	3.68e-06	7.16e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—osteoporosis	3.67e-06	7.15e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.6e-06	7.01e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.35e-06	6.51e-05	CbGpPWpGaD
